1.05
Catheter Precision Inc. stock is traded at $1.05, with a volume of 102.12K.
It is up +0.00% in the last 24 hours and up +37.98% over the past month.
Catheter Precision, Inc. develops and delivers electrophysiology products to provide patients, hospitals, and physicians with technologies and solutions to improve the lives of patients with cardiac arrhythmias in the United States. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. It also provides LockeT, a suture retention device; and Amigo Remote Catheter System, a robotic arm that serves as a catheter control device. The company was formerly known as Ra Medical Systems, Inc and changed its name to Catheter Precision, Inc. in August 2023. Catheter Precision, Inc. is based in Fort Mill, South Carolina.
See More
Previous Close:
$1.05
Open:
$1.03
24h Volume:
102.12K
Relative Volume:
0.74
Market Cap:
$2.83M
Revenue:
$819.00K
Net Income/Loss:
$-17.70M
P/E Ratio:
-0.0829
EPS:
-12.6647
Net Cash Flow:
$-8.45M
1W Performance:
+2.94%
1M Performance:
+37.98%
6M Performance:
-53.02%
1Y Performance:
-84.86%
Catheter Precision Inc. Stock (VTAK) Company Profile
Name
Catheter Precision Inc.
Sector
Industry
Phone
973 691 2000
Address
1670 Highway 160 West, Suite 205, Fort Mill
Compare VTAK vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
VTAK
Catheter Precision Inc.
|
1.05 | 2.83M | 819.00K | -17.70M | -8.45M | -12.66 |
|
ABT
Abbott Laboratories
|
88.67 | 154.45B | 45.13B | 6.28B | 7.38B | 3.5895 |
|
SYK
Stryker Corp
|
307.94 | 118.05B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
80.38 | 103.20B | 36.36B | 4.84B | 5.43B | 3.7212 |
|
BSX
Boston Scientific Corp
|
46.76 | 69.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
86.28 | 49.68B | 6.30B | 1.07B | 1.09B | 1.8406 |
Catheter Precision Inc. Stock (VTAK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-13-19 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Nov-02-18 | Initiated | Maxim Group | Buy |
Catheter Precision Inc. Stock (VTAK) Latest News
Volato ends M2i merger agreement, gains new investors - Private Jet Card Comparisons
VTAK Q1 2025 Earnings: EPS Misses Estimates Significantly, Revenue Not ReportedCFO Commentary Report - newsline.com
FLYTE EXPANDS STRATEGIC RELATIONSHIP WITH VOLATO BY JOINING VAUNT PLATFORM - marketscreener.com
Private flights aim at 2026 World Cup traffic in Northeast - Stock Titan
Flyte Acquires 7.5% Stake in Volato to Expand Aviation Technology Ecosystem - citybiz
Catheter Precision's Flyte Acquires 7.5% Stake in Volato - marketscreener.com
Catheter Precision subsidiary invests in Volato Group By Investing.com - Investing.com South Africa
Flyte backs Volato with 7.5% stake, eyeing private aviation tie-ups - Stock Titan
Catheter Precision Makes Strategic Investment in Volato Group - TipRanks
Volato secures $2.2M investment led by Catheter Precision By Investing.com - Investing.com South Africa
Volato Group, Inc. and Catheter Precision, Inc. Enter Registration Rights Agreement for Common Stock Offering - Minichart
Catheter Precision (NYSE: VTAK) to buy $1M stake in Volato stock - Stock Titan
Volato Group, Inc. announced that it expects to receive $2.21 million in funding from Catheter Precision, Inc. - marketscreener.com
VTAK Stock Chart | CATHETER PRECISION INC (NYSEARCA:VTAK) - ChartMill
Belmont Stakes weekend to see private shuttle flight surge - Stock Titan
FLYTE ACTIVATES HIGH-FREQUENCY BELMONT STAKES FLIGHT PROGRAM, DEPLOYING FLEET TO CAPTURE TRIPLE CROWN DEMAND - Yahoo Finance
VTAK Stock Price, Quote & Chart | CATHETER PRECISION INC (NYSEARCA:VTAK) - ChartMill
VTAK Q1 2025 Earnings: Significant EPS Miss Amid Operational ChallengesEarnings Call Transcript - newsline.com
Catheter Precision Inc. (VTAK) Q1 2025 Earnings: Deep EPS Miss With No Revenue, Stock SlidesGrowth Acceleration Report - newsline.com
VTAK Q1 2025 Earnings: Wider-than-Expected Loss Sends Stock LowerStrong Earnings Momentum - The Legal Advocate
VTAK Q1 2025 Earnings: Wider Loss Than Expected Amid No Revenue GenerationEarnings Yield Analysis - The Legal Advocate
VTAK Q1 2025 Earnings: EPS Miss Widens as Revenue Remains UnreportedProfit Margin Analysis - The Legal Advocate
Catheter Precision Inc. (VTAK) Q1 2025 Earnings: Significant EPS Miss and No Revenue ReportedQuarterly Earnings - The Legal Advocate
Catheter Precision Company Profile & Introduction - Moomoo
Catheter Precision (VTAK) Q1 2025 Earnings: Significant EPS Miss as Stock Rises Amid Strategic Progress - Newser
Catheter Precision Inc. (VTAK) Gains 5.7% as Micro-Cap Stock Tests Resistance Near $0.88Volatility Breakout Picks - The Legal Advocate
Catheter Precision reports net loss of USD 1.7M in Q1 2026 - Medical Buyer
FLYTE ACTIVATES HIGH-FREQUENCY MEMORIAL DAY WEEKEND FLIGHT NETWORK TO CAPTURE SURGING NORTHEAST DEMAND - Yahoo Finance
Catheter Precision, Inc. (VTAK) Q1 2026 10-Q Report: Financials, Warrants, and Segment Details - Minichart
Catheter Precision (NYSE: VTAK) triples Q1 revenue and adds Flyte aviation - Stock Titan
Catheter Precision reports 200% revenue growth in Q1 2026 By Investing.com - Investing.com Nigeria
Catheter Precision reports 200% revenue growth in Q1 2026 - Investing.com
Catheter Precision Announces Brief 10-Q Filing Delay - TipRanks
CATHETER PRECISION REPORTS 200% REVENUE GROWTH AND COMPLETES TRANSFORMATIVE FLYTE ACQUISITION - marketscreener.com
Medical device firm’s Q1 sales jump 200% after Flyte jet deal - Stock Titan
Catheter Precision, Inc. 1Q 2026: Revenue $432K, EPS ($1.39) — 10-Q Summary - TradingView
Catheter Precision: Revenue rose with FLYTE acquisition, but liquidity and dilution risks remain high - TradingView
Catheter Precision, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Catheter Precision (NYSE: VTAK) adds aviation unit but flags going concern risk - Stock Titan
Catheter Precision (NASDAQ: VTAK) delays Q1 2026 10-Q after March 9 acquisitions - Stock Titan
Number of shareholders of Catheter Precision, Inc. – FWB:4RM - TradingView
Catheter Precision (VTAK) Q1 2025 Results Miss Estimates — EPS $-6.65 vs $-3.88EBITDA Margin Trends - Newser
VTAK Should I Buy - Intellectia AI
Catheter Precision (VTAK) 13G/A: Affiliates Report 0% Beneficial Ownership - Stock Titan
FLYTE ACTIVATES HIGH-FREQUENCY PREAKNESS FLIGHT PROGRAM, DEPLOYING FLEET TO SERVE STRONG NORTHEAST DEMAND - The Manila Times
Sub-one-hour Preakness flights: Flyte offers I-95 alternative - Stock Titan
What Catheter Precision (VTAK) management is focused on executing | Q1 2025: Below ExpectationsSecondary Offering - newser.com
VTAK: Catheter Precision, Inc.Interactive Chart - Zacks Investment Research
Catheter Precision Inc. Stock (VTAK) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cap:
|
Volume (24h):